Psoriasis Monotherapies dissent Little in Effectiveness Medscape April 16, 2012 — A recent cross-sectional examination comparing psoriasis monotherapies with methotrexate, adalimumab, etanercept, ustekinumab, and narrow-band ultraviolet-B (UV-B) found small differences in response that may not be clinically significant. Link To Article
No comments:
Post a Comment